蛋白质囊泡作为药物输送,疫苗和免疫治疗的新兴平台
Nishat Tasnim1, Yeongseon Jang1
1Department of Chemical Engineering, University of Florida, Gainesville, Florida, USA;
Annual review of chemical and biomolecular engineering
|March 6, 2026
概括
蛋白质囊泡为药物输送提供了与合成囊泡的生物相容和可调节的替代品. 这些以蛋白质为基础的载体在生物医学应用中显示出增强稳定性,向输送和受控释放的前景.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 蛋白质囊泡是用蛋白质构建的新型生物材料,具有生物相容性和可调节性质.
- 现有的合成囊泡,如脂质体和聚合体,在稳定性和向传递方面存在局限性.
- 基于蛋白质的载体在药物和疫苗输送方面有着悠久的历史,但囊泡架构提供了增强的优势.
研究的目的:
- 总结一下最近在工程蛋白质囊泡方面的进展.
- 将蛋白质囊泡与其他合成囊泡 (脂质体,聚合体,病毒样粒子) 进行比较.
- 突出蛋白质囊泡在生物医学中的独特益处和新兴应用.
主要方法:
- 关于蛋白质囊泡工程的最新文献的综述.
- 对蛋白质囊泡与脂质体,聚合体和病毒样颗粒进行比较分析.
- 评估蛋白质囊泡在治疗,诊断和免疫治疗中的应用.
主要成果:
- 与自由蛋白相比,蛋白质囊泡表现出优越的稳定性,有针对性的输送和受控释放.
- 蛋白质囊泡在生物相容性和结构性可调性方面比传统合成囊泡具有优势.
- 新兴的应用表明了先进的治疗和诊断方面的潜力.
结论:
- 蛋白质囊泡代表生物医学应用的一类有前途的合成囊泡.
- 需要进一步的研究来将蛋白质囊泡技术转化为临床应用.
- 蛋白质囊泡为开发下一代治疗和诊断提供了一个独特的平台.
相关概念视频
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
67
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
67
Drug Delivery Systems: Different Types
134
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
134
Drug Delivery: Overview
1.1K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.1K
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis
4.1K
Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
4.1K
Modified-Release Drug Delivery Systems: Overview
76
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
76


